| Neoadjuvant chemotherapy and immunotherapy in luminal B-like breast cancer: results of the phase II GIADA trial MV Dieci, V Guarneri, A Tosi, G Bisagni, A Musolino, S Spazzapan, ... Clinical Cancer Research 28 (2), 308-317, 2022 | 67 | 2022 |
| Adoptive cell therapy of triple negative breast cancer with redirected cytokine-induced killer cells R Sommaggio, E Cappuzzello, A Dalla Pietà, A Tosi, P Palmerini, ... Oncoimmunology 9 (1), 1777046, 2020 | 46 | 2020 |
| Retargeting cytokine-induced killer cell activity by CD16 engagement with clinical-grade antibodies E Cappuzzello, A Tosi, P Zanovello, R Sommaggio, A Rosato Oncoimmunology 5 (8), e1199311, 2016 | 40 | 2016 |
| The immune cell landscape of metastatic uveal melanoma correlates with overall survival A Tosi, R Cappellesso, AP Dei Tos, V Rossi, C Aliberti, J Pigozzo, ... Journal of Experimental & Clinical Cancer Research 40, 1-17, 2021 | 32 | 2021 |
| Hyaluronan is a natural and effective immunological adjuvant for protein-based vaccines A Dalla Pietà, D Carpanese, A Grigoletto, A Tosi, S Dalla Santa, ... Cellular & Molecular Immunology 18 (5), 1197-1210, 2021 | 18 | 2021 |
| Identification of a HLA-A* 0201-restricted immunogenic epitope from the universal tumor antigen DEPDC1 A Tosi, S Dalla Santa, E Cappuzzello, C Marotta, D Walerich, G Del Sal, ... Oncoimmunology 6 (8), e1313371, 2017 | 12 | 2017 |
| Reduction of T lymphoma cells and immunological invigoration in a patient concurrently affected by melanoma and Sezary syndrome treated with Nivolumab MG Narducci, A Tosi, A Frezzolini, E Scala, F Passarelli, L Bonmassar, ... Frontiers in Immunology 11, 579894, 2020 | 5 | 2020 |
| Reduced interleukin-17-expressing cells in cutaneous melanoma A Tosi, L Nardinocchi, ML Carbone, L Capriotti, E Pagani, S Mastroeni, ... Biomedicines 9 (12), 1930, 2021 | 4 | 2021 |
| Profiling of immune checkpoint biomarkers by multiplex immunofluorescence in breast cancer brain metastases. G Griguolo, A Tosi, V Guarneri, MV Dieci, S Fineberg, A Ventura, ... Journal of Clinical Oncology 39 (15_suppl), 2021-2021, 2021 | 1 | 2021 |
| Immune microenvironment profiling of breast cancer brain metastases using multiplex immunofluorescence. G Griguolo, A Tosi, V Guarneri, MV Dieci, S Fineberg, A Ventura, ... Journal of Clinical Oncology 38 (15_suppl), 2526-2526, 2020 | 1 | 2020 |
| Characterization of new FSHβ-derived peptide probes for the validation of FSHR as a new prognostic and predictive biomarker in primary and metastatic cancers D Carpanese, C Bolzati, A Tosi, A Penna, S Brunello, IM Montagner, ... Nuclear Medicine and Biology 96, S89, 2021 | | 2021 |
| Identification of a HLA-A0201-restricted immunogenic epitope from the universal tumor antigen DEPDC1 (vol 6, 2017) A Tosi, SD Santa, E Cappuzzello, C Marotta, D Walerych, G Del Sal, ... ONCOIMMUNOLOGY 7 (1), 2018 | | 2018 |
